BioSpace News Archive

Neuritek Therapeutics, Ltd. (Neuritek), a biotech company incorporated under the laws of the United Kingdom whose principal place of business is at 200 W 57th Street, New York, NY 10019, United States announced that it has signed an agreement with GEM Global Yield LLC SCS

Arizona physicians adopt CGM ELVI Telemedicine to offer virtual consultations, reduce office visits

The study represents one of the largest published datasets on refugee eye health

Jobs Available in Indiana, Ohio, Tennessee, and Texas Caring for Individuals with Intellectual and Developmental Disabilities

3M is committed to combating price gouging, fraud and counterfeit activity in connection with its products and the COVID-19 outbreak.

Aclaris Therapeutics, Inc., a physician-led biopharmaceutical company, announced that it has entered into a loan and security agreement with Silicon Valley Bank pursuant to which Aclaris has borrowed $11.0 million.

Prothena Corporation plc announced that baseline data from the Phase 2 PASADENA study of prasinezumab in patients with early Parkinson’s disease will be presented by Roche in an oral presentation at the Advances in Alzheimer’s and Parkinson’s Therapies AAT-AD/PD Focus Meeting, to be held virtually on April 2-5, 2020.

3M Chairman and CEO Mike Roman issued the following update announcing additional details about 3M’s capacity increases of N95 respirators, strong measures to combat price gouging and counterfeiting, and new partnerships to help protect our healthcare workers on the front lines:

Pharmacists are tireless responders on the front lines of health care as our nation faces the COVID-19 pandemic.

In a collaborative effort with state bioscience leaders from around the country, MichBio held a webinar discussing the state of biodefense readiness, emerging treatments and vaccines for COVID-19, and the path to approval and mass production of essential therapeutic, diagnostic, and vaccine products in response to the ongoing pandemic.